SCHEMBL17429810

SCHEMBL17429810

CCCc1c(C)ccc2[nH]cc(C(=O)O)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ HTT P42858 1/20 0.40
▸ F7 P08709 1/20 0.39
▸ F3 P13726 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ PSMD14 O00487 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ PRKAB2 O43741 1/20 0.38
▸ PRKAG1 P54619 1/20 0.38
▸ PRKAA2 P54646 1/20 0.38
▸ PRKAA1 Q13131 1/20 0.38
▸ PRKAG3 Q9UGI9 1/20 0.38
▸ PRKAG2 Q9UGJ0 1/20 0.38
▸ PRKAB1 Q9Y478 1/20 0.38
▸ NOTUM Q6P988 1/20 0.36
▸ PPARG P37231 1/20 0.36
▸ DRD2 P14416 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6451616 0.78 HSD17B10 (0.47) CYP1A2HSD17B10HTTF7F3
SCHEMBL17417700 0.75 HSD17B10 (0.45) CYP1A2HSD17B10HTTF7F3
SCHEMBL17417691 0.75 F7 (0.50) CYP1A2HSD17B10F7F3KDM4E
SCHEMBL20551861 0.75 KMT2A (0.49) CYP1A2HSD17B10KDM4ERECQLLMNA
SCHEMBL17417754 0.73 HSD17B10 (0.43) CYP1A2HSD17B10F7F3KDM4E
SCHEMBL8226800 0.73 GABRP (0.41) CYP1A2HSD17B10KDM4ELDHALDHB
SCHEMBL3995494 0.71 GPR84 (0.51) CYP1A2HSD17B10F7F3KDM4E
SCHEMBL28732290 0.71 PPARA (0.41) KDM4EPPARGRAB9ALDHALDHB
SCHEMBL28512376 0.71 LDHA (0.47) CYP1A2HSD17B10KDM4EPPARGLMNA
SCHEMBL2045109 0.70 HSD17B10 (0.43) CYP1A2HSD17B10HTTF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016007630-A1 QUINUCLIDINE COMPOUNDS FOR MODULATING ALPHA7 -NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY ALPHARMAGEN, LLC (US) 2016-01-14 — — WO disclosed
Send feedback